Dr. Ali Fatemi is a co-founder of ALD Connect. He is the Chief Medical Officer at Kennedy Krieger Institute, a pediatric neurologist and the director of the Division of Neurogenetics and the Moser Center for Leukodystrophies, an investigator at the Hugo W. Moser Research Institute at Kennedy Krieger Institute and holds the Blum-Moser Chair for Pediatric Neurology. Dr. Fatemi is also professor of neurology and pediatrics at Johns Hopkins University.
Main Area of Research: Our preclinical lab focuses on understanding the myelin pathobiology in ALD and the role of neuroinflammation (efforts led by Nadav Weinstock and Ann Moser), development of novel therapeutics (led by Dr. Christina Mertz) in mouse and in vitro models of ALD. The clinical research focuses on development and validation of various outcome measures including neuroimaging and omics based biomarkers. We are part of a strong collaborative multi center consortium led by CHOP, KKI and MGH Leukodystrophy teams.